InvestorsHub Logo
Followers 5
Posts 189
Boards Moderated 0
Alias Born 07/24/2016

Re: None

Monday, 01/02/2017 1:46:16 AM

Monday, January 02, 2017 1:46:16 AM

Post# of 3988
$PLX 45c Could double or more this week as the company releases positive top line data for its Phase 2 drug for Cystic fibrosis. Going after $700M Pulmozime Genentech drug. It already showed superiority over Pulmozime in tests before. The company has other blockbuster drugs in Phases 2 and 3 with an addressable market exceeding $10B. The balance sheet has been recently strengthened and management believes it is well funded through 2019 with current cash and sales of its 1st FDA approved.....

It's all here:


http://seekingalpha.com/article/4033076-protalix-biotherapeutics-receives-24m-order-well-funded-significant-upside

Wise and patient investors will hold this gem for a year or two to realize its full potential of $5++. THere are not many opportunities like this left in the market these days.


Happy New Year to all of you!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News